Structural heart disease screening using artificial intelligence–enabled electrocardiogram and novice handheld cardiac ultrasound: a cost analysis
European Heart Journal Open · 05.03.2026 · 6 (2)
DOI: 10.1093/ehjopen/oeag049 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 30.03.2026. Verfasst von Reid P Schlesinger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Early detection of structural heart disease (SHD) improves patient outcomes. However, population-based screening is not recommended due to the lack of accurate and cost-effective tools. We evaluated the costs of artificial intelligence–enabled electrocardiogram (AI-ECG) alone vs. AI-ECG followed by handheld cardiac ultrasound (HCU) for SHD screening. Methods and results We performed a model-based cost analysis using data from 286 adult patients who underwent ECG and same-day HCU performed by a novice operator. Transthoracic echocardiogram (TTE) was the reference standard. We compared two screening strategies: (i) AI-ECG alone and (ii) a stepwise approach (AI-ECG followed by HCU). We assessed costs per diagnosis of aortic stenosis (AS), increased left ventricular wall thickness (ILVWT), and left ventricular systolic dysfunction (LVSD). Sensitivity analyses were conducted for varying disease prevalence. The stepwise approach decreased the cost per diagnosis of AS from $6386 (AI-ECG alone) to $2746 (57.0% savings), ILVWT from $4448 to $2895 (34.9% savings), and LVSD from $1469 to $1296 (11.8% savings). Overall, the cost per diagnosis for all SHDs combined decreased from $1940 to $1570 (19.1% savings). Sensitivity analysis demonstrated that cost savings were inversely proportional to disease prevalence. Nevertheless, stepwise screening remained cost-saving compared with AI-ECG alone until prevalence exceeded ∼55.9% for AS, 28.9% for ILVWT, 20.7% for LVSD, and 40.8% for all SHDs combined.
Conclusion
A stepwise screening strategy incorporating HCU after a positive AI-ECG reduces the immediate costs of SHD detection by minimizing unnecessary TTEs. This approach may enhance the feasibility of population-based SHD screening, particularly in lower-prevalence settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
ORCID-Profile: Reid P Schlesinger, Vuyisile T Nkomo, Francisco Lopez-Jimenez, Sorin V Pislaru
Zitieren
APA
Schlesinger, R. P., Alexandrino, F. B., Lee, E., Deshmukh, A. J., Nkomo, V. T., Oh, J. K., Noseworthy, P. A., Pellikka, P. A., Zachi, A., Lopez-Jimenez, F., Friedman, P. A., Kane, G. C., Pislaru, S. V., Bird, J., & Tsaban, G. (2026). Structural heart disease screening using artificial intelligence–enabled electrocardiogram and novice handheld cardiac ultrasound: a cost analysis. European Heart Journal Open, 6(2). https://doi.org/10.1093/ehjopen/oeag049
Vancouver
Schlesinger RP, Alexandrino FB, Lee E, Deshmukh AJ, Nkomo VT, Oh JK, et al. Structural heart disease screening using artificial intelligence–enabled electrocardiogram and novice handheld cardiac ultrasound: a cost analysis. European Heart Journal Open. 2026;6(2). doi:10.1093/ehjopen/oeag049
BibTeX
@article{Schlesinger2026,
author = {Schlesinger, Reid P and Alexandrino, Francisco B and Lee, Eunjung and Deshmukh, Abhishek J and Nkomo, Vuyisile T and Oh, Jae K and Noseworthy, Peter A and Pellikka, Patricia A and Zachi, Attia and Lopez-Jimenez, Francisco and Friedman, Paul A and Kane, Garvan C and Pislaru, Sorin V and Bird, Jared and Tsaban, Gal},
title = {Structural heart disease screening using artificial intelligence–enabled electrocardiogram and novice handheld cardiac ultrasound: a cost analysis},
journal = {European Heart Journal Open},
year = {2026},
volume = {6},
number = {2},
doi = {10.1093/ehjopen/oeag049}
}
EUVIMED